Free Trial

Quantum-Si Incorporated (QSI) - What Are Investment Firms Thinking About This Stock?

Quantum-Si logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts’ consensus rating is “Hold” across five brokerages: three rate QSI a buy, one a hold and one a sell. Their average 12-month price target is $2.50.
  • Quantum-Si reported quarterly EPS of -$0.10, better than the -$0.12 consensus estimate, but revenue of $0.21 million fell short of the $0.27 million estimate.
  • Institutional investors own 39.9% of the stock. QSI traded at $1.23 in the cited session, within a 12-month range of $0.69 to $1.81.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $2.50.

Several brokerages have recently issued reports on QSI. Weiss Ratings raised shares of Quantum-Si from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, September 24th. HC Wainwright reissued a "buy" rating on shares of Quantum-Si in a research note on Thursday. Alliance Global Partners restated a "buy" rating on shares of Quantum-Si in a report on Friday, August 14th. Wall Street Zen upgraded shares of Quantum-Si from a "sell" rating to a "hold" rating in a research report on Tuesday, October 27th. Finally, UBS Group reaffirmed a "buy" rating on shares of Quantum-Si in a report on Thursday.

View Our Latest Report on QSI

Institutional Investors Weigh In On Quantum-Si

Several hedge funds have recently modified their holdings of the stock. Commonwealth Equity Services LLC purchased a new stake in Quantum-Si during the third quarter valued at about $29,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Quantum-Si during the third quarter valued at approximately $39,000. Verdence Capital Advisors LLC acquired a new stake in shares of Quantum-Si during the third quarter valued at approximately $143,000. IPG Investment Advisors LLC purchased a new stake in shares of Quantum-Si in the 2nd quarter valued at approximately $27,000. Finally, WINTON GROUP Ltd acquired a new position in Quantum-Si in the 2nd quarter worth approximately $67,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Stock Performance

Shares of QSI stock traded down $0.04 during mid-day trading on Thursday, hitting $1.23. 1,969,017 shares of the stock traded hands, compared to its average volume of 5,287,510. Quantum-Si has a twelve month low of $0.69 and a twelve month high of $1.81. The firm has a market cap of $268.13 million, a price-to-earnings ratio of -3.14 and a beta of 3.26. The company's 50-day simple moving average is $1.12 and its 200-day simple moving average is $0.97.

Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported ($0.10) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.02. The business had revenue of $0.21 million during the quarter, compared to analyst estimates of $0.27 million. Quantum-Si had a negative return on equity of 44.72% and a negative net margin of 6,729.80%. Analysts forecast that Quantum-Si will post -0.47 earnings per share for the current year.

Quantum-Si Company Profile

(Get Free Report)

Quantum-Si Incorporated NASDAQ: QSI is a life sciences technology company focused on transforming protein analysis through next-generation proteomics. The company develops tools designed to identify and characterize proteins at the single-molecule level, with potential applications in drug discovery, translational research, diagnostics development and precision medicine. Its primary offering is the Platinum platform, which combines a benchtop sequencing instrument, semiconductor-based technology, consumables and data-analysis software.

Featured Stories

Analyst Recommendations for Quantum-Si (NASDAQ:QSI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantum-Si Right Now?

Before you consider Quantum-Si, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.

While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines